DNR Capital Australian Emerging Companies Fund receives positive research ratings – now accessible on leading investment platforms.
Thursday, May 09 2019
DNR Capital, a leading Australian equities investment manager, reported that its recently launched small cap fund, the DNR Capital Australian Emerging Companies Fund, has received ‘Investment Grade’ rating from Lonsec and an ‘Approved’ Rating from Zenith Investment Partners.
The Fund is currently available to financial advisers via the Netwealth, HUB24 and Praemium investment platforms.
Launched in August 2018, the Fund offers investors a concentrated exposure to Australian small companies. DNR Capital’s investment process takes a long-term approach, identifying high quality small cap companies trading at attractive valuations. Sam Twidale and Mark Sedawie are the Portfolio Managers for the Fund, which consists of between 20 and 45 of their highest conviction ideas.
Lonsec noted: “The Fund provides investors with access to DNR Capital’s highly regarded bottom up stock selection approach seeking to build a portfolio of quality small cap companies trading at attractive valuations.”
Zenith reported: “Although Twidale and Sedawie are responsible for the research coverage of all companies in the Fund’s smaller companies universe, they draw upon the insights of the broader investment team. Zenith believes this is a positive for the Fund.”
Mr Twidale said: “The Australian small cap sector is a particularly inefficient part of the market, providing significant opportunities to add value from applying a consistent and proven investment process. We believe our quality discipline is even more relevant to this part of the market, with the Fund providing exposure to a number of niche opportunities and fast growing trends. This includes successful domestic companies expanding into significantly larger global markets, disruption in financials as new business models compete with established players, and the impact of new emerging technologies and rising corporate IT spend.”
Robert White, DNR Capital CEO added, “We are seeing growing interest in this Fund and are encouraged by the support from consultants, advisers and investment platforms that have listed the Fund to their investment menu. DNR Capital has generated a consistent track record of outperformance over the last 16 years, and we are confident of repeating this in the small cap sector.”
IMPORTANT NOTE: The information relating to DNR Capital has been prepared by DNR Capital Pty Ltd, AFS Representative – 294844 of DNR AFSL Pty Ltd ABN 39 118 946 400, AFSL 301658. Whilst DNR Capital has used its best endeavours to ensure the information within this document is accurate it cannot be relied upon in any way and you must make your own enquiries concerning the accuracy of the information within. The information in this document has been prepared for general purposes and does not take into account your particular investment objectives, financial situation or needs, nor does it constitute investment advice. Before making any financial investment decisions you should obtain legal and taxation advice appropriate to your particular needs. DNR Capital will not be responsible or liable to anyone who acts or relies upon anything contained in, or omitted from, this document. Past performance is not indicative of future performance.
The Lonsec Rating (assigned January 2019) presented in this document is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445. The Rating is limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial product(s). Past performance information is for illustrative purposes only and is not indicative of future performance. It is not a recommendation to purchase, sell or hold DNR Capital’s product(s), and you should seek independent financial advice before investing in this product(s). The Rating is subject to change without notice and Lonsec assumes no obligation to update the relevant document(s) following publication. Lonsec receives a fee from the Fund Manager for researching the product(s) using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at: http://www.lonsecresearch.com.au/research-solutions/our-ratings
The Zenith Investment Partners (“Zenith”) Australian Financial Services License No. 226872 rating (assigned February 2019) referred to in this document is limited to “General Advice” (as defined by the Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Zenith usually charges the product issuer, fund manager or a related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessment’s and at https://www.zenithpartners.com.au/our-solutions/investment-research/fund-research-regulatory-guidelines/